Evidence map›Paper›PMID 36200896›Full record

ArticleMicrobiology spectrum2022

Chromosome-Level Genome Sequences, Comparative Genomic Analyses, and Secondary-Metabolite Biosynthesis Evaluation of the Medicinal Edible Mushroom Laetiporus sulphureus.

Wei-Ge Dong, Zhen-Xin Wang, Xi-Long Feng, Rui-Qi Zhang, Dao-Yin Shen, Shuangtian Du, Jin-Ming Gao, Jianzhao Qi

Abstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. The First Whole Genome Sequence and Methylation Profile ofJournal of fungi (Basel, Switzerland) · 2025
    Article
  7. Genomic Sequencing and Characterization of TwoJournal of fungi (Basel, Switzerland) · 2025
    Article
  8. Genome Sequencing and Metabolic Potential Analysis ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  9. Genomic Features ofJournal of fungi (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Natural and engineered xylosyl products from microbial source.Natural products and bioprospecting · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. The First Five Mitochondrial Genomes for the FamilyInternational journal of molecular sciences · 2023
    Article
  18. The First Whole Genome Sequencing ofJournal of fungi (Basel, Switzerland) · 2023
    Article
  19. The Possibility of Using Sulphur Shelf Fungus (Foods (Basel, Switzerland) · 2023
    Review
  20. Whole Genome Sequence of an Edible MushroomJournal of fungi (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Wei-Ge Dong *Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi, China.
Zhen-Xin Wang *Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi, China.
Xi-Long FengShaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi, China.
Rui-Qi ZhangShaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi, China.
Dao-Yin ShenYangling Zhijun Fungi Biotechnology Engineering Co., Ltd., Yangling, Shaanxi, China.
Shuangtian DuShaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi, China.
Jin-Ming GaoShaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi, China.
Jianzhao QiShaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi, China.ORCID 0000-0003-1418-873X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Laetiporus sulphureus mushroom is a complementary and alternative medicine that has anticancer, antioxidation, and analgesic effects and immunomodulatory activity; it is used as a treatment for cough and rheumatism and is a functional food that can improve physical fitness. Even though L. sulphureus has garnered considerable biotechnological and pharmacological interest due to its excellent cellulose-degrading ability and diverse biological activities, its biosynthetic potential regarding polysaccharides and secondary metabolites has not been thoroughly examined. In this study, we sequenced and assembled the whole genome of a wild

Indexed as

AgaricalesBasidiomycotaBiological ProductsPolyketidesRheumatic DiseasesTriterpenesAnalgesicsCarbohydratesCelluloseChromosomesCoughGenomicsTerpenesAnalgesicsBiological ProductsCarbohydratesCellulosePolyketidesTerpenesTriterpenesbiosynthetic potentialLaetiporus sulphureusnear-chromosome level assemblypharmaceutical edible mushroomsecondary metabolite

Identifiers

PMID36200896
PMCPMC9602373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.